These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 17597972)
1. Pharmacologic treatment of SARS: current knowledge and recommendations. Tai DY Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972 [TBL] [Abstract][Full Text] [Related]
3. Advancements in the battle against severe acute respiratory syndrome. Hui DS; Wong GW Expert Opin Pharmacother; 2004 Aug; 5(8):1687-93. PubMed ID: 15264983 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
6. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Chan KS; Lai ST; Chu CM; Tsui E; Tam CY; Wong MM; Tse MW; Que TL; Peiris JS; Sung J; Wong VC; Yuen KY Hong Kong Med J; 2003 Dec; 9(6):399-406. PubMed ID: 14660806 [TBL] [Abstract][Full Text] [Related]
7. Infectious diseases. Battling SARS on the frontlines. Normile D Science; 2003 May; 300(5620):714-5. PubMed ID: 12730562 [No Abstract] [Full Text] [Related]
8. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY; Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565 [TBL] [Abstract][Full Text] [Related]
12. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907 [TBL] [Abstract][Full Text] [Related]
13. [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP Antibiot Khimioter; 2011; 56(7-8):42-6. PubMed ID: 22359870 [TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment. Tsang K; Seto WH Curr Opin Investig Drugs; 2004 Feb; 5(2):179-85. PubMed ID: 15043392 [TBL] [Abstract][Full Text] [Related]
15. Development of antiviral therapy for severe acute respiratory syndrome. Cinatl J; Michaelis M; Hoever G; Preiser W; Doerr HW Antiviral Res; 2005 Jun; 66(2-3):81-97. PubMed ID: 15878786 [TBL] [Abstract][Full Text] [Related]
16. Treatment of SARS with human interferons. Antonelli G; Scagnolari C; Vicenzi E; Clementi M Lancet; 2003 Oct; 362(9390):1158; author reply 1158-9. PubMed ID: 14550714 [No Abstract] [Full Text] [Related]
17. COVID-19 in Children: Clinical Approach and Management. Sankar J; Dhochak N; Kabra SK; Lodha R Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347 [TBL] [Abstract][Full Text] [Related]
18. Current status of anti-SARS agents. Shigeta S; Yamase T Antivir Chem Chemother; 2005; 16(1):23-31. PubMed ID: 15739619 [TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum coronavirus antiviral drug discovery. Totura AL; Bavari S Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]